🇺🇸 FDA
Pipeline program

REGN88

6R88-RA-0802

Phase 1 mab completed

Quick answer

REGN88 for Rheumatoid Arthritis is a Phase 1 program (mab) at Regeneron UK Limited with 3 ClinicalTrials.gov record(s).

Program details

Company
Regeneron UK Limited
Indication
Rheumatoid Arthritis
Phase
Phase 1
Modality
mab
Status
completed

Clinical trials